Sponsor or institution
Clinical trials and research at Taizhou Mabtech Pharmaceutical Co.,Ltd
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Taizhou Mabtech Pharmaceutical Co.,Ltd that are recruiting, in China. By phase: Phase 1 (1), Phase 3 (1), Phase 4 (1), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Anyouping® plus Enlituo® with platinum-based chemotherapy as first-line for advanced head and neck cancer | Phase 2/3 | Shanghai, Shanghai Municipality | Recruiting | Aug 28, 2026 |
| Enlituo plus FOLFOX vs Erbitux plus FOLFOX in advanced/metastatic colorectal cancer | Phase 3 | Guangzhou | Recruiting | May 19, 2026 |
| CMAB017 for safety and tolerability in advanced solid tumors | Phase 1 | Shanghai | Recruiting | Apr 18, 2025 |
| Registry of Infliximab for Children with Crohn's Disease in China | Phase 4 | Beijing | Recruiting | Jun 18, 2023 |
All recruiting trials (4)
-
Anyouping® plus Enlituo® with platinum-based chemotherapy as first-line for advanced head and neck cancer
This trial tests whether adding Anyouping® and Enlituo® to standard platinum-based chemo helps adults with advanced, recurring, or metastatic head and neck squamous cell carcinoma succeed more than standard chemo alone.
-
Enlituo plus FOLFOX vs Erbitux plus FOLFOX in advanced/metastatic colorectal cancer
This phase 3 trial tests whether Enlituo added to FOLFOX works as well as Erbitux added to FOLFOX for people with RAS/BRAF wild-type and MSS/pMMR colorectal cancer.
-
CMAB017 for safety and tolerability in advanced solid tumors
This trial tests whether the experimental antibody CMAB017 is safe and tolerated in adults with advanced solid tumors who have exhausted or declined standard treatments.
-
Registry of Infliximab for Children with Crohn's Disease in China
This study is testing how well Infliximab works and how safe it is for children aged 6 to 17 with moderate to severe Crohn's disease in China.
Quick answers
How many clinical trials run by Taizhou Mabtech Pharmaceutical Co.,Ltd are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 3: 1, Phase 4: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.